Three experts have resigned from FDA’s advisory committee following the agency’s approval of Biogen’s Alzheimer’s drug, aducanumab, according to multiple reports.
FDA approved...
Johnson & Johnson recently announced efficacy and safety data for its biologic therapy, Stelara (ustekinumab) in treating patients with Crohn’s disease and ulcerative colitis.
The...
Thermo Fisher Scientific and the University of California (UCSF) recently formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies.
Under the terms of...
NHS England recently announced that it is rolling out its 3D imaging technology, HeartFlow, to diagnose and treat nearly 1,000 patients with suspected heart disease.
HeartFlow, part of NHS Long Term...
Moderna recently announced that it will increase global 2022 capacity for its COVID-19 vaccine to up to 3 billion doses, boosting production at its owned and partnered manufacturing facilities.
The...
Biogen recently announced new data from its portfolio of multiple sclerosis (MS) therapies.
The updates include data on quality of life benefits and findings from analyses on extended interval dosing...
FDA recently authorized marketing of the GI Genius, a medical device that uses artificial intelligence (AI) to assist clinicians in detecting signs of colon cancer.
GI Genius is based on machine...
Eli Lilly and Company and Biolojic Design recently announced a research agreement to discover and develop potential novel antibody therapies for the treatment of diabetes.
The collaboration and...
Researchers recently developed a promising new blueprint for an RNA-based vaccine for malaria, which contains similar properties as the novel RNA COVID-19 vaccines.
Novartis Pharmaceutical and...
Pfizer recently announced that it has invested $120 million in four clinical-stage companies that focus on biotechnology innovation, oncology, rare disease, and immunology treatments.
Through the...
FDA recently issued an emergency use authorization (EUA) for the first over-the-counter (OTC), at-home COVID-19 diagnostics test.
The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test,...
Data analytics and business intelligence company Definitive Healthcare continues to expand its footprint in the life sciences space with the acquisition of Monocl, the company announced.
Headquartered...
Mount Sinai researchers recently released additional information regarding the positive connection between anticoagulation therapy and improved survival among hospitalized COVID-19 patients.
For more...
In patients with Alzheimer’s disease, a daily dose of dopamine agonist, rotigotine, showed no significant benefit from baseline to 24 weeks when compared with a placebo, according to a JAMA...
Scientists from the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre for Advanced Research (OSCAR) recently developed a new company to launch a COVID-19 rapid...
GSK and Medicago recently announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s...
New data from real-world evidence suggests that simultaneous insulin and GLP-1 RA therapies could provide more effective blood sugar control in patients with uncontrolled type 2 diabetes.
Researchers...
AbbVie and Genmab recently signed a broad collaboration agreement to jointly develop and commercialize Genmab’s three early-stage investigational antibody therapeutics for cancer.
Genmab...
Eli Lilly and Company recently announced that the first patient has been enrolled in a Phase 3 clinical trial to evaluate the efficacy and safety of baricitinib in hospitalized patients with...
Preliminary data from a clinical trial found that a commonly used steroid – dexamethasone – improves survival in hospitalized COVID-19 patients, according to a press release from Oxford...
